REACH

Trial Acronym REACH
Clinical Area Primary Care
Description An evaluation of a multifaceted intervention to reduce antimicrobial prescribing in care home residents [REducing Antimicrobials in Care Homes (REACH)]: a non-randomised pilot study and process evaluation.
Status Closed
RECRUITMENT
Date Opened to Recruitment April 2017
Target Recruitment 6 Nursing/Residential Homes (120 residents)
Recruitment to date 6 Nursing/Residential Homes (Completed)
TRIAL DESIGN
Trial Design The Reducing Antimicrobials in Care Homes (REACH) study is a non-randomised feasibility study that employs a mixed methods design.
Study Aim The aim of this study is to evaluate the feasibility and acceptability of a multifaceted intervention on rational prescribing for infections in a non-randomised feasibility study in care homes.
CHIEF INVESTIGATOR (CI)
Chief Investigator Professor Carmel Hughes
SPONSOR(s) & FUNDER(s)
Sponsor Queen’s University Belfast
Funder NIHR_Health Services and Delivery Research (HS&DR)
LINKS
Links http://www.controlled-trials.com/ISRCTN10441831